查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1733621

全球核子造影设备市场－按产品、应用、最终用户、地区、预测的市场规模

Global Nuclear Imaging Equipment Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

核子造影设备市场规模及预测

2024 年核子造影设备市场规模为 28.6 亿美元，预计到 2032 年将达到 40.3 亿美元，2026 年至 2032 年的复合年增长率为 4.85%。

核子造影设备是指用于核子医学观察和评估体内器官和组织功能的专用医疗设备。这种成像技术使用少量放射性物质（称为放射性药物或放射性示踪剂），其发射伽马射线，由机器检测以创建图像。

核成像设备旨在根据器官的生理功能（而不仅仅是其结构外观）捕捉影像，并且不同于X光和电脑断层扫描等传统成像方式。

核子影像设备广泛用于诊断多种疾病，包括癌症、心臟病等。核子造影设备使医疗保健提供者能够监测器官功能并评估病情进展。

核子医学扫描术诊断通常是非侵入性的、无痛的，这使其成为现代诊断中的有价值的工具。

核子造影设备的全球市场动态

影响全球核子造影设备市场的关键市场动态是：

关键市场驱动因素

诊断程序的需求不断增加：每年有超过 3,000 万名患者使用核医和分子成像技术进行诊断或治疗，凸显了对这些技术进行准确诊断和治疗计划的依赖性日益增强。

技术进步：SPECT/CT、PET/CT等先进影像技术的发展与融合，提升了诊断能力。核能总署(IAEA) 报告称，全球已安装超过 27,000 套 SPECT 系统和 5,200 套 PET 系统，显示这些技术已被广泛采用。

慢性病的增加：慢性病，尤其是癌症和心血管疾病的增加推动了对有效诊断的需求。核子医学扫描术诊断在肿瘤学的诊断、分期和治疗监测中起着重要作用，已成为现代医学的重要组成部分。

支持性法规环境：美国美国核能管理委员会(NRC) 和食品药物管理局(FDA) 等监管机构提供促进核子医学摄影技术安全使用的指导方针。这种监管支持刺激了创新并鼓励医疗机构投资新设备。

主要市场问题

遵守严格的规定：核子影像领域受到美国美国核能管理委员会(NRC) 和食品药物管理局(FDA) 等机构的严格监管。这些规定要求严格遵守安全标准，包括设备校准和剂量记录。 NRC 要求各设施定期进行区域调查，以确保辐射水平低于规定的阈值，这使医疗保健提供者的业务变得复杂。

资本成本高：PET 和 SPECT 扫描仪等核成像设备的初始投资和维护成本对于许多医疗机构来说过高，尤其是在发展中地区。这些经济障碍限制了人们获得先进诊断技术的机会，进而影响了整个市场。

技术的复杂性：核子成像技术的快速发展需要对医务人员进行持续的培训和教育。如果医务人员没有接受充分培训，操作先进设备的复杂性可能会导致错误，从而危及患者的安全和诊断的准确性。

来自替代成像方式的竞争：非核成像技术，例如 MRI 和电脑断层扫描，已经显着提高了分辨率，并且通常是医疗保健提供者有吸引力的选择，这可能会减少核成像技术的市场占有率。这些模式的广泛采用可能会分散核成像领域的资金和注意力。

主要市场趋势：

先进技术的整合：将人工智慧 (AI) 和机器学习整合到核成像系统（尤其是 SPECT 成像）中越来越流行。这种整合将增强影像分析，提高诊断准确性并增加业务效率。美国国立卫生研究院 (NIH) 正在积极资助该领域的研究，以透过先进的影像技术改善患者的治疗效果。

混合影像系统：SPECT/CT 和 PET/CT 等混合影像系统的开发和采用正在增加。这些系统将核子医学的功能性影像与电脑断层扫描的解剖影像相结合，提供全面的诊断资讯。据核能（IAEA）称，混合系统显着提高了各个医疗领域的诊断准确性和定位性。

新型放射性药物的出现：新型放射性药物的引进正在扩大核子造影的应用。这些进步使得对特定疾病进行更有针对性的成像成为可能，并提高了诊断方法的有效性。美国食品药物管理局（FDA）近年来核准了几种新的放射性药物，反映出该领域的创新日益增多。

关注病人安全：人们越来越重视在核子医学影像检查中减少病患的辐射暴露。 NRC 等监管机构提倡将辐射暴露保持在尽可能低的合理水平 (ALARA)，这是在不影响影像品质的情况下提高安全性的技术进步背后的驱动力。

目录

第一章：全球核子造影设备市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章核子造影设备全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球核子造影设备市场（按产品）

  • 概述
  • SPECT 系统
  • 混合PET系统
  • 平面闪烁扫描

第六章全球核子造影设备市场（按应用）

  • 概述
  • 瘤
  • 心
  • 神经
  • 其他的

第七章全球核子造影设备市场（按最终用户）

  • 概述
  • 医院
  • 影像中心
  • 学术研究中心
  • 其他的

8. 全球核子造影设备市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

9. 全球核子造影设备市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • Siemens AG
  • GE Healthcare
  • Philips Healthcare
  • Digirad Corporation
  • Surgiceye GmbH

第十一章 附录

  • 相关调查
简介目录
Product Code: 38088

Nuclear Imaging Equipment Market Size And Forecast

Nuclear Imaging Equipment Market size was valued at USD 2.86 Billion in 2024 and is projected to reach USD 4.03 Billion by 2032, growing at a CAGR of 4.85% from 2026 to 2032.

Nuclear imaging equipment refers to specialized medical devices used in nuclear medicine to visualize and assess the function of organs and tissues within the body. This imaging technique utilizes small amounts of radioactive materials, known as radiopharmaceuticals or radiotracers, which emit gamma rays that are detected by the equipment to create images.

Nuclear imaging equipment is designed to capture images based on the physiological function of organs rather than just their structural appearance, distinguishing it from traditional imaging modalities like X-rays or CT scans.

Nuclear imaging equipment is widely used for diagnosing various conditions, including cancers, heart disease, and other It allows healthcare providers to monitor organ function and assess disease progression.

Nuclear imaging is generally non-invasive and painless, making it a valuable tool in modern diagnostics.

Global Nuclear Imaging Equipment Market Dynamics

The key market dynamics that are shaping the global nuclear imaging equipment market include:

Key Market Drivers:

Increasing Demand for Diagnostic Procedures: Over 30 million patients are diagnosed or treated annually using nuclear medicine and molecular imaging techniques, highlighting the growing reliance on these technologies for accurate diagnosis and treatment planning.

Advancements in Technology: The development and integration of advanced imaging technologies, such as SPECT/CT and PET/CT, have enhanced diagnostic capabilities. The International Atomic Energy Agency (IAEA) reports that over 27,000 SPECT systems and more than 5,200 PET systems are installed worldwide, indicating widespread adoption of these technologies.

Growing Prevalence of Chronic Diseases: The rise in chronic diseases, particularly cancers and cardiovascular disorders, drives the demand for effective diagnostic Nuclear imaging is critical in oncology for diagnosis, staging, and treatment monitoring, making it an essential component of modern healthcare.

Supportive Regulatory Environment: Regulatory bodies, such as the S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA), provide guidelines that facilitate the safe use of nuclear imaging technologies. This regulatory support fosters innovation and encourages healthcare facilities to invest in new equipment.

Key Market Challenges:

Stringent Regulatory Compliance: The nuclear imaging sector is subject to rigorous regulations imposed by bodies like the U.S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA). These regulations require strict adherence to safety standards, including calibration of equipment and documentation of administered dosages. The NRC mandates that facilities conduct regular area surveys to ensure radiation doses remain below specified thresholds, complicating operational procedures for healthcare providers.

High Equipment Costs: The initial investment and maintenance costs for nuclear imaging equipment, such as PET and SPECT scanners, can be prohibitively high for many healthcare facilities, especially in developing regions. This financial barrier limits access to advanced diagnostic technologies, impacting overall market

Technological Complexity: The rapid advancements in nuclear imaging technology necessitate continuous training and education for medical staff. The complexity of operating sophisticated equipment can lead to errors if personnel are not adequately trained, which can compromise patient safety and diagnostic accuracy.

Competition from Alternative Imaging Modalities: Non-nuclear imaging techniques, such as MRI and CT scans, have seen significant advancements in resolution and These alternatives often provide compelling options for healthcare providers, leading to potential market share loss for nuclear imaging technologies. The increasing adoption of these modalities can divert funding and attention away from nuclear imaging.

Key Market Trends:

Integration of Advanced Technologies: There is a growing trend towards integrating artificial intelligence (AI) and machine learning into nuclear imaging systems, particularly in SPECT imaging. This integration enhances image analysis, improves diagnostic accuracy, and increases operational efficiency. The National Institutes of Health (NIH) is actively funding research in this area to improve patient outcomes through advanced imaging techniques.

Hybrid Imaging Systems: The development and adoption of hybrid imaging systems, such as SPECT/CT and PET/CT, are on the rise. These systems combine functional imaging from nuclear medicine with anatomical imaging from CT scans, providing comprehensive diagnostic information. According to the International Atomic Energy Agency (IAEA), hybrid systems have significantly improved diagnostic accuracy and localization in various medical fields.

Emergence of New Radiopharmaceuticals: The introduction of novel radiopharmaceuticals is expanding the applications of nuclear imaging. These advancements allow for more targeted imaging of specific diseases, enhancing the effectiveness of diagnostic procedures. The U.S. Food and Drug Administration (FDA) has approved several new radiotracers in recent years, reflecting the ongoing innovation in this area.

Focus on Patient Safety: There is an increasing emphasis on reducing radiation exposure to patients during nuclear imaging procedures. Regulatory bodies like the NRC advocate for practices that keep radiation doses as low as reasonably achievable (ALARA), which is driving technological advancements aimed at improving safety without compromising image quality.

Global Nuclear Imaging Equipment Market Regional Analysis

Here is a more detailed regional analysis of the global nuclear imaging equipment market:

North America:

North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging

The region faces a growing incidence of chronic diseases, particularly cancer and cardiovascular The International Agency for Research on Cancer projects that by 2025, the worldwide cancer prevalence will reach over 50 million, driving the need for effective diagnostic tools like nuclear imaging.

North America is at the forefront of technological advancements in nuclear imaging, including the development of hybrid systems like SPECT/CT and PET/CT. These innovations enhance diagnostic accuracy and are supported by funding from organizations such as the National Institutes of Health (NIH), which promotes research in advanced imaging techniques.

The increasing elderly population in North America contributes to a higher demand for diagnostic procedures. As older adults are more susceptible to chronic diseases requiring regular monitoring, this demographic trend further fuels the growth of nuclear imaging services.

Europe:

Europe is expected to account for a substantial portion of the global nuclear imaging equipment market, driven by a high number of product launches and advancements in technology. For instance, the region's market share is projected to grow significantly due to innovations from companies like Siemens Healthineers and Philips

The European Medicines Agency (EMA) and national regulatory bodies enforce stringent regulations that ensure high safety and efficacy standards for nuclear imaging This regulatory environment fosters innovation while ensuring patient safety.

The rise in chronic diseases, particularly cancer and cardiovascular conditions, is a significant driver of demand for nuclear imaging. According to the World Health Organization (WHO), cancer was responsible for approximately 1 in 6 deaths globally in 2020, highlighting the need for effective diagnostic tools.

The aging population in Europe is driving demand for diagnostic imaging services. By 2030, it is estimated that over 25% of the EU population will be over 65 years old, increasing the prevalence of age-related diseases that require advanced imaging

Global Nuclear Imaging Equipment Market: Segmentation Analysis

The Global Nuclear Imaging Equipment Market is Segmented based on Product, Application, End-User, And Geography.

Nuclear Imaging Equipment Market, By Product

  • SPECT Imaging Systems
  • PET Imaging Systems
  • Planar Scintigraphy Imaging Systems

Based on Product, the global Nuclear Imaging Equipment market is divided into SPECT Imaging Systems, PET Imaging Systems, and Planar Scintigraphy Imaging Systems. SPECT imaging systems hold a significant share of the nuclear imaging market, driven by their widespread use in various diagnostic applications, including cardiology, oncology, and neurology. The global SPECT market is projected to grow from approximately $2.1 billion in 2022 to $4.7 billion by 2032, reflecting a robust CAGR of 8.5% during this period.

Nuclear Imaging Equipment Market, By Application

  • Oncology
  • Cardiology
  • Neurology

Based on Application, the market is segmented into Oncology, Cardiology, and Neurology. The oncology segment is expected to account for a significant portion of the nuclear imaging equipment market, with estimates indicating it held over 49% of the market share in 2022. This dominance is driven by the rising incidence of cancer globally, necessitating advanced diagnostic tools for effective detection and treatment planning.

Nuclear Imaging Equipment Market, By End-User

  • Hospitals
  • Imaging Centers
  • Academic & Research Centers

Based on End-User, the market is fragmented into Hospitals, Home Care Settings, Ambulatory Surgery Centers, and Laboratories and Clinics. The hospitals segment accounted for over 52.75% of the nuclear imaging equipment market in 2023. This significant share reflects the extensive use of nuclear imaging technologies in hospital settings for various diagnostic procedures.

Nuclear Imaging Equipment Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Geography, the Global Nuclear Imaging Equipment Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging technologies.

Key Players

The "Global Nuclear Imaging Equipment Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, Absolute Imaging, Inc., pectrum Dynamics, CMR Naviscan., TTG Imaging Solutions, Lucero Dynamics, Berthold Technologies GmbH & COKG, and Siemens Healthineers. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above- mentioned players globally.

  • Nuclear Imaging Equipment Market Recent Developments
  • In March 2023, Digirad Corporation launched its nSPEED 3D reconstruction software, which enhances imaging speed and reduces patient dosing This software is part of Digirad's commitment to advancing nuclear imaging technology and improving patient comfort.
  • In April 2023, Canon Medical Systems introduced the Cartesion Prime Digital PET- CT system, which features advanced AI technology for enhanced image quality and speed. This system is designed to improve disease pathology assessment and facilitate tailored treatment approaches.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 SPECT Systems
  • 5.3 Hybrid PET Systems
  • 5.4 Planar Scintigraphy

6 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Oncology
  • 6.3 Cardiology
  • 6.4 Neurology
  • 6.5 Others

7 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Imaging Centers
  • 7.4 Academic and Research Centers
  • 7.5 Others

8 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Siemens AG
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 GE Healthcare
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Philips Healthcare
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Digirad Corporation
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Surgiceye GmbH
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments

11 Appendix

  • 11.1 Related Research